(20 ILCS 5135/1) (Section scheduled to be repealed on January 1, 2021) Sec. 1. Short title. This Act may be cited as the Prescription Drug Task Force Act. (Source: P.A. 100-989, eff. 8-20-18.)

(20 ILCS 5135/5) (Section scheduled to be repealed on January 1, 2021) Sec. 5. Purpose. The General Assembly finds that:(1) Prescription opioid abuse is endemic in this State.(2) Some medical studies have shown that the use of opioid versus non-opioid medication therapy did not result in significantly better pain-related function over the trial periods.(3) While opioid abuse is an endemic public health problem, there are patients in pain who may need opioids for legitimate medical reasons.(4) It has the right to regulate the licensing of health care professionals and has enacted various licensing Acts for that purpose authorizing the Department of Financial and Professional Regulation to license and discipline these health care professionals.(5) A legislative Task Force is necessary to study prescription opioid abuse, and to make recommendations of future legislation to address this issue. (Source: P.A. 100-989, eff. 8-20-18.)

(20 ILCS 5135/10) (Section scheduled to be repealed on January 1, 2021) Sec. 10. Prescription Drug Task Force. (a) The Prescription Drug Task Force is created. The Task Force shall be composed of 25 members appointed as follows:(1) one member of the House of Representatives

appointed by the Speaker of the House of Representatives;

(2) one member of the House of Representatives

appointed by the Minority Leader of the House of Representatives;

(3) one member of the Senate appointed by the

President of the Senate;

(4) one member of the Senate appointed by the

Minority Leader of the Senate;

(5) the Secretary of Human Services or his or her

designee;

(6) one member from each of the following

organizations appointed by the Secretary of Human Services from nominees made by the respective organization:

(A) a statewide organization representing

advanced practice registered nurses;

(B) a statewide organization representing

hospitals;

(C) a statewide organization representing retail

merchants;

(D) a statewide organization representing

dentists;

(E) a statewide organization representing

physician assistants;

(F) a statewide organization representing

health-system pharmacists;

(G) a statewide organization representing

optometrists;

(H) a statewide organization representing

pharmacists;

(I) a statewide organization representing

pharmaceutical manufacturers;

(7) 2 members who are parents whose children have

died from drug overdoses, appointed by the Secretary of Human Services;

(8) 2 members who are selected from county sheriffs,

municipal police chiefs, and State's Attorneys, appointed by the Attorney General;

(9) one member who is a peace officer specializing in

the enforcement of laws prohibiting the illegal manufacture, delivery, and possession of controlled substances and methamphetamine, appointed by the Director of State Police;

(10) 2 members who are representatives of providers

of addiction treatment services, appointed by the Secretary of Human Services;

(11) 2 members who are public defenders, appointed by

the Attorney General; and

(12) 2 members who are physicians licensed to

practice medicine in all its branches, including one physician specializing in pain management and one physician specializing in emergency medicine, nominated by a statewide organization representing physicians licensed to practice medicine in all its branches, appointed by the Secretary of Human Services.

(b) The Task Force shall choose its chairperson from among its members and any other officers it deems appropriate.(c) The Task Force shall initially meet within 30 days after the effective date of this Act. The members of the Task Force shall receive no compensation for their services as members of the Task Force but may be reimbursed for expenses from appropriations made by law.(d) The Task Force may seek the assistance of the Departments of Financial and Professional Regulation and Public Health in performing its duties.(e) The Task Force shall:(1) study prescription opioid abuse in this State;(2) study the over-prescription of opioids such as

Hydrocodone and Oxycodone; and

(3) recommend any legislation, including amendments

to the Illinois Controlled Substances Act, that would have the effect of reducing opioid addiction and abuse.

(f) The Task Force shall focus its efforts in a manner that best utilizes the unique skills and perspectives of the experts on the Task Force.(g) The Task Force shall submit a report of its recommendations to the General Assembly on or before December 31, 2019. The report to the General Assembly shall be filed with the Clerk of the House of Representatives and the Secretary of the Senate in electronic form only, in the manner that the Clerk and the Secretary shall direct. (h) The Department of Human Services shall provide administrative and other support to the Task Force.(i) This Act is repealed on January 1, 2021. (Source: P.A. 100-989, eff. 8-20-18.)

(20 ILCS 5135/99) (Section scheduled to be repealed on January 1, 2021) Sec. 99. Effective date. This Act takes effect upon becoming law. (Source: P.A. 100-989, eff. 8-20-18.)